BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18089447)

  • 1. Novel mechanisms in accelerated atherosclerosis in kidney disease.
    Shah SV; Apostolov EO; Ok E; Basnakian AG
    J Ren Nutr; 2008 Jan; 18(1):65-9. PubMed ID: 18089447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells.
    Asci G; Basci A; Shah SV; Basnakian A; Toz H; Ozkahya M; Duman S; Ok E
    Nephrology (Carlton); 2008 Dec; 13(6):480-6. PubMed ID: 18518940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease.
    Ok E; Basnakian AG; Apostolov EO; Barri YM; Shah SV
    Kidney Int; 2005 Jul; 68(1):173-8. PubMed ID: 15954906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease.
    Apostolov EO; Basnakian AG; Ok E; Shah SV
    J Ren Nutr; 2012 Jan; 22(1):134-8. PubMed ID: 22200430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamylated LDL.
    Basnakian AG; Shah SV; Ok E; Altunel E; Apostolov EO
    Adv Clin Chem; 2010; 51():25-52. PubMed ID: 20857617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic uremia stimulates LDL carbamylation and atherosclerosis.
    Apostolov EO; Ray D; Savenka AV; Shah SV; Basnakian AG
    J Am Soc Nephrol; 2010 Nov; 21(11):1852-7. PubMed ID: 20947625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells?
    Gouni-Berthold I; Sachinidis A
    FASEB J; 2002 Oct; 16(12):1477-87. PubMed ID: 12374770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells.
    Carracedo J; Merino A; Briceño C; Soriano S; Buendía P; Calleros L; Rodriguez M; Martín-Malo A; Aljama P; Ramírez R
    FASEB J; 2011 Apr; 25(4):1314-22. PubMed ID: 21228221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of inflammatory markers and endothelial function.
    Järvisalo MJ; Juonala M; Raitakari OT
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):547-52. PubMed ID: 16912549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of low density lipoprotein carbamylation by vitamins, as an ameliorating atherosclerotic risk in uremic patients.
    Ghaffari MA; Shanaki M
    Scand J Clin Lab Invest; 2010 Apr; 70(2):122-7. PubMed ID: 20156036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In atherogenesis, the apoptosis of endothelial cell itself could directly induce over-proliferation of smooth muscle cells.
    Qin C; Liu Z
    Med Hypotheses; 2007; 68(2):275-7. PubMed ID: 17011140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of inflammation in atherogenesis].
    Rodríguez G; Mago N; Rosa F
    Invest Clin; 2009 Mar; 50(1):109-29. PubMed ID: 19418732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein.
    Bedel A; Nègre-Salvayre A; Heeneman S; Grazide MH; Thiers JC; Salvayre R; Maupas-Schwalm F
    Circ Res; 2008 Sep; 103(7):694-701. PubMed ID: 18703780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor.
    Wang SH; Lin SJ; Chen YH; Lin FY; Shih JC; Wu CC; Wu HL; Chen YL
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):816-22. PubMed ID: 19342598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
    Ratto E; Leoncini G; Viazzi F; Pontremoli R
    G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamylated Low-Density Lipoproteins Induce a Prothrombotic State Via LOX-1: Impact on Arterial Thrombus Formation In Vivo.
    Holy EW; Akhmedov A; Speer T; Camici GG; Zewinger S; Bonetti N; Beer JH; Lüscher TF; Tanner FC
    J Am Coll Cardiol; 2016 Oct; 68(15):1664-1676. PubMed ID: 27712780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamylated Low-Density Lipoprotein (cLDL)-Mediated Induction of Autophagy and Its Role in Endothelial Cell Injury.
    Bose C; Shah SV; Karaduta OK; Kaushal GP
    PLoS One; 2016; 11(12):e0165576. PubMed ID: 27973558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression.
    Chang WC; Yu YM; Chiang SY; Tseng CY
    Br J Nutr; 2008 Apr; 99(4):709-14. PubMed ID: 18184451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium and vascular smooth muscle cells in the context of uremia.
    Günthner T; Jankowski V; Kretschmer A; Nierhaus M; van der Giet M; Zidek W; Jankowski J
    Semin Dial; 2009; 22(4):428-32. PubMed ID: 19708995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.